Media about us

• Domain partners with RusNano on $760M biotech investment plan

  06 March 2012 John Carroll, Fierce Biotech

  

  The Russians are back. After capturing the attention of the nanobio crowd with a few hefty investments in the U.S., RusNano is now partnering with Domain Associates on a $760 million initiative that will invest in about 20 life sciences companies and construct a pharma manufacturing center in Russia to produce next-gen therapies.

• Rusnano Teams Up With U.S. Fund Domain to Invest in Life Science

  06 March 2012 Jason Corcoran, BLOOMBERG

  

  Russian Nanotechnologies Corp. plans to work with Domain Associates, a U.S. venture fund, to invest $760 million in U.S. life science companies and build facilities in Russia.